Letter to the Editor: The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer
J Med Virol
.
2023 Mar;95(3):e28664.
doi: 10.1002/jmv.28664.
Authors
Abdulkerim Uygur
1
,
Uğurcan Sayılı
1
Affiliation
1
Department of Public Health, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
PMID:
36905217
DOI:
10.1002/jmv.28664
No abstract available
Publication types
Letter
Comment
MeSH terms
BNT162 Vaccine*
Humans
Neoplasms* / therapy
Substances
BNT162 Vaccine
sinovac COVID-19 vaccine